Tha├ži, D., Armstrong, A., Gordon, K. B., Blauvelt, A., Paul, C., Boehncke, W.-H., Wang, M., Szilagyi, B. ., Hoepken, B., Lambert, J., & Lebwohl, M. (2024). Bimekizumab 3-year Maintenance of Response in Week 16 Responders with Moderate to Severe Plaque Psoriasis: Results from Five Phase 3/3b Trials. SKIN The Journal of Cutaneous Medicine, 8(1), s306. https://doi.org/10.25251/skin.8.supp.306